Skip to main navigation Skip to search Skip to main content

A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate

  • Tsutomu Takeuchi
  • , Yoshiya Tanaka
  • , Chieri Higashitani
  • , Megumi Iwai
  • , Kanji Komatsu
  • , Rio Akazawa
  • , Christopher Lademacher

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases